speb/financial-data huggingface dataset:
ICCM balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1810000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1810000.00
ICCM balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 129487000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 129487000.00
ICCM balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -3000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -3000.00
ICCM income_statement (annual, 2025-12-31) — Basic Average Shares: 2119308.00
ICCM income_statement (annual, 2025-12-31) — Basic EPS: -7.20
ICCM cash_flow (annual, 2025-12-31) — Beginning Cash Position: 7564000.00
ICCM cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 4971000.00
ICCM cash_flow (annual, 2025-12-31) — Capital Expenditure: -36000.00
ICCM cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -5000.00
ICCM balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 217000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 217000.00
ICCM balance_sheet (annual, 2025-12-31) — Capital Stock: 0.00
ICCM balance_sheet (quarterly, 2025-12-31) — Capital Stock: 0.00
ICCM balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 8897000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 8897000.00
ICCM balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8897000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8897000.00
ICCM cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 15834000.00
ICCM cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 3720000.00
ICCM cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -36000.00
ICCM cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 4995000.00
ICCM cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -14574000.00
ICCM cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -5019000.00
ICCM cash_flow (annual, 2025-12-31) — Change In Account Payable: -369000.00
ICCM cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -288000.00
ICCM cash_flow (annual, 2025-12-31) — Change In Inventory: -637000.00
ICCM cash_flow (quarterly, 2025-12-31) — Change In Inventory: 86000.00
ICCM cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 327000.00
ICCM cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 76000.00
ICCM cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -413000.00
ICCM cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -550000.00
ICCM cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -98000.00
ICCM cash_flow (annual, 2025-12-31) — Change In Payable: -369000.00
ICCM cash_flow (quarterly, 2025-12-31) — Change In Payable: -288000.00
ICCM cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -369000.00
ICCM cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -288000.00
ICCM cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 229000.00
ICCM cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 84000.00
ICCM cash_flow (annual, 2025-12-31) — Change In Receivables: -110000.00
ICCM cash_flow (quarterly, 2025-12-31) — Change In Receivables: -227000.00
ICCM cash_flow (annual, 2025-12-31) — Change In Working Capital: -1071000.00
ICCM cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -917000.00
ICCM cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -110000.00
ICCM cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -227000.00
ICCM cash_flow (annual, 2025-12-31) — Changes In Cash: 1224000.00
ICCM cash_flow (quarterly, 2025-12-31) — Changes In Cash: 3696000.00
ICCM balance_sheet (annual, 2025-12-31) — Common Stock: 0.00
ICCM balance_sheet (quarterly, 2025-12-31) — Common Stock: 0.00
ICCM balance_sheet (annual, 2025-12-31) — Common Stock Equity: 9051000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 9051000.00
ICCM cash_flow (annual, 2025-12-31) — Common Stock Issuance: 15539000.00
ICCM cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 3717000.00
ICCM income_statement (annual, 2025-12-31) — Cost Of Revenue: 2153000.00
ICCM income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 679000.00
ICCM balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 779000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 779000.00
ICCM balance_sheet (annual, 2025-12-31) — Current Assets: 12605000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Current Assets: 12605000.00
ICCM balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 204000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 204000.00
ICCM balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 204000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 204000.00
ICCM balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 255000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 255000.00
ICCM balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 255000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 255000.00
ICCM balance_sheet (annual, 2025-12-31) — Current Liabilities: 4824000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 4824000.00
ICCM balance_sheet (annual, 2025-12-31) — Current Provisions: 64000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Current Provisions: 64000.00
ICCM cash_flow (annual, 2025-12-31) — Depreciation: 295000.00
ICCM cash_flow (quarterly, 2025-12-31) — Depreciation: 71000.00
ICCM cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 295000.00
ICCM cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 71000.00
ICCM cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 295000.00
ICCM cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 71000.00
ICCM income_statement (annual, 2025-12-31) — Diluted Average Shares: 2119308.00
ICCM income_statement (annual, 2025-12-31) — Diluted EPS: -7.20
ICCM income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -15057000.00
ICCM income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -4246000.00
ICCM income_statement (annual, 2025-12-31) — EBIT: -15094000.00
ICCM income_statement (quarterly, 2025-12-31) — EBIT: -4216000.00
ICCM income_statement (annual, 2025-12-31) — EBITDA: -14799000.00
ICCM income_statement (quarterly, 2025-12-31) — EBITDA: -4145000.00
ICCM cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 109000.00
ICCM cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 230000.00
ICCM cash_flow (annual, 2025-12-31) — End Cash Position: 8897000.00
ICCM cash_flow (quarterly, 2025-12-31) — End Cash Position: 8897000.00
ICCM cash_flow (annual, 2025-12-31) — Financing Cash Flow: 15834000.00
ICCM cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 3720000.00
ICCM balance_sheet (annual, 2025-12-31) — Finished Goods: 549000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Finished Goods: 549000.00
ICCM cash_flow (annual, 2025-12-31) — Free Cash Flow: -14610000.00
ICCM cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -5024000.00
ICCM income_statement (annual, 2025-12-31) — General And Administrative Expense: 7850000.00
ICCM income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 4544000.00
ICCM balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 334000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 334000.00
ICCM balance_sheet (annual, 2025-12-31) — Gross PPE: 3042000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Gross PPE: 3042000.00
ICCM income_statement (annual, 2025-12-31) — Gross Profit: 1226000.00
ICCM income_statement (quarterly, 2025-12-31) — Gross Profit: 600000.00
ICCM balance_sheet (annual, 2025-12-31) — Inventory: 2625000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Inventory: 2625000.00
ICCM balance_sheet (annual, 2025-12-31) — Invested Capital: 9051000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Invested Capital: 9051000.00
ICCM cash_flow (annual, 2025-12-31) — Investing Cash Flow: -36000.00
ICCM cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 4995000.00
ICCM cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 15539000.00
ICCM cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 3717000.00
ICCM cash_flow (annual, 2025-12-31) — Issuance Of Debt: 2000000.00
ICCM balance_sheet (annual, 2025-12-31) — Leases: 212000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Leases: 212000.00
ICCM balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 13000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 13000.00
ICCM balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 13000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 13000.00
ICCM cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 2000000.00
ICCM cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -2000000.00
ICCM balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 600000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 600000.00
ICCM cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 15539000.00
ICCM cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 3717000.00
ICCM cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -114000.00
ICCM cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -232000.00
ICCM income_statement (annual, 2025-12-31) — Net Income: -15057000.00
ICCM income_statement (quarterly, 2025-12-31) — Net Income: -4246000.00
ICCM income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -15057000.00
ICCM income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -4246000.00
ICCM income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -15057000.00
ICCM income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -4246000.00
ICCM income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -15057000.00
ICCM income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -4246000.00
ICCM income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -15057000.00
ICCM income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -4246000.00
ICCM cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -15057000.00
ICCM cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -4246000.00
ICCM income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -15057000.00
ICCM income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -4246000.00
ICCM income_statement (annual, 2025-12-31) — Net Interest Income: 37000.00
ICCM income_statement (quarterly, 2025-12-31) — Net Interest Income: -30000.00
ICCM cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 0.00
ICCM cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 5000000.00
ICCM cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
ICCM cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
ICCM income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 37000.00
ICCM income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -30000.00
ICCM balance_sheet (annual, 2025-12-31) — Net PPE: 1232000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Net PPE: 1232000.00
ICCM cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -36000.00
ICCM cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -5000.00
ICCM balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 9051000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 9051000.00
ICCM income_statement (annual, 2025-12-31) — Normalized EBITDA: -14799000.00
ICCM income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -4145000.00
ICCM income_statement (annual, 2025-12-31) — Normalized Income: -15057000.00
ICCM income_statement (quarterly, 2025-12-31) — Normalized Income: -4246000.00
ICCM cash_flow (annual, 2025-12-31) — Operating Cash Flow: -14574000.00
ICCM cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -5019000.00
ICCM cash_flow (annual, 2025-12-31) — Operating Gains Losses: -114000.00
ICCM cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -232000.00
ICCM income_statement (annual, 2025-12-31) — Operating Income: -15094000.00
ICCM income_statement (quarterly, 2025-12-31) — Operating Income: -4216000.00
ICCM income_statement (annual, 2025-12-31) — Operating Revenue: 3379000.00
ICCM income_statement (quarterly, 2025-12-31) — Operating Revenue: 1279000.00
ICCM balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 2437409.00
ICCM balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 2437409.00
ICCM income_statement (annual, 2025-12-31) — Other Gand A: 2852000.00
ICCM income_statement (quarterly, 2025-12-31) — Other Gand A: -454000.00
ICCM balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 51000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 51000.00
ICCM balance_sheet (annual, 2025-12-31) — Other Properties: 2230000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Other Properties: 2230000.00
ICCM balance_sheet (annual, 2025-12-31) — Other Receivables: 1000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1000.00
ICCM balance_sheet (annual, 2025-12-31) — Payables: 863000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Payables: 863000.00
ICCM balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 1642000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1642000.00
ICCM balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2659000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2659000.00
ICCM balance_sheet (annual, 2025-12-31) — Prepaid Assets: 539000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 539000.00
ICCM income_statement (annual, 2025-12-31) — Pretax Income: -15057000.00
ICCM income_statement (quarterly, 2025-12-31) — Pretax Income: -4246000.00
ICCM cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 295000.00
ICCM cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 3000.00
ICCM balance_sheet (annual, 2025-12-31) — Properties: 0.00
ICCM balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ICCM cash_flow (annual, 2025-12-31) — Purchase Of Investment: -5000000.00
ICCM cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
ICCM cash_flow (annual, 2025-12-31) — Purchase Of PPE: -36000.00
ICCM cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -5000.00
ICCM balance_sheet (annual, 2025-12-31) — Raw Materials: 1805000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Raw Materials: 1805000.00
ICCM balance_sheet (annual, 2025-12-31) — Receivables: 544000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Receivables: 544000.00
ICCM income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 2153000.00
ICCM income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 679000.00
ICCM income_statement (annual, 2025-12-31) — Reconciled Depreciation: 295000.00
ICCM income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 71000.00
ICCM cash_flow (annual, 2025-12-31) — Repayment Of Debt: -2000000.00
ICCM income_statement (annual, 2025-12-31) — Research And Development: 7433000.00
ICCM income_statement (quarterly, 2025-12-31) — Research And Development: 2296000.00
ICCM balance_sheet (annual, 2025-12-31) — Retained Earnings: -120436000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -120436000.00
ICCM income_statement (annual, 2025-12-31) — Salaries And Wages: 4998000.00
ICCM cash_flow (annual, 2025-12-31) — Sale Of Investment: 5000000.00
ICCM cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 5000000.00
ICCM income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 1037000.00
ICCM income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: -2024000.00
ICCM income_statement (annual, 2025-12-31) — Selling General And Administration: 8887000.00
ICCM income_statement (quarterly, 2025-12-31) — Selling General And Administration: 2520000.00
ICCM balance_sheet (annual, 2025-12-31) — Share Issued: 2437409.00
ICCM balance_sheet (quarterly, 2025-12-31) — Share Issued: 2437409.00
ICCM cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1373000.00
ICCM cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 271000.00
ICCM balance_sheet (annual, 2025-12-31) — Stockholders Equity: 9051000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 9051000.00
ICCM balance_sheet (annual, 2025-12-31) — Tangible Book Value: 9051000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 9051000.00
ICCM income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ICCM income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ICCM income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
ICCM income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
ICCM balance_sheet (annual, 2025-12-31) — Taxes Receivable: 212000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 212000.00
ICCM balance_sheet (annual, 2025-12-31) — Total Assets: 13888000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Total Assets: 13888000.00
ICCM balance_sheet (annual, 2025-12-31) — Total Capitalization: 9051000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 9051000.00
ICCM balance_sheet (annual, 2025-12-31) — Total Debt: 217000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Total Debt: 217000.00
ICCM balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 9051000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 9051000.00
ICCM income_statement (annual, 2025-12-31) — Total Expenses: 18473000.00
ICCM income_statement (quarterly, 2025-12-31) — Total Expenses: 5495000.00
ICCM balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 4837000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 4837000.00
ICCM balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1283000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1283000.00
ICCM balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 13000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 13000.00
ICCM income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -15094000.00
ICCM income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -4216000.00
ICCM income_statement (annual, 2025-12-31) — Total Other Finance Cost: -37000.00
ICCM income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 30000.00
ICCM balance_sheet (annual, 2025-12-31) — Work In Process: 271000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Work In Process: 271000.00
ICCM balance_sheet (annual, 2025-12-31) — Working Capital: 7781000.00
ICCM balance_sheet (quarterly, 2025-12-31) — Working Capital: 7781000.00
ICCM income_statement (quarterly, 2026-03-31) — +Operating Expense: 4542000.00
ICCM income_statement (quarterly, 2026-03-31) — +Total Revenue: 911000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 988000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 274000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 133204000.00
ICCM income_statement (quarterly, 2026-03-31) — Basic Average Shares: 2452442.00
ICCM income_statement (quarterly, 2026-03-31) — Basic EPS: -1.80
ICCM cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 8897000.00
ICCM cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -51000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 139000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Capital Stock: 0.00
ICCM balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 8115000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 8115000.00
ICCM cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 3537000.00
ICCM cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -51000.00
ICCM cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -4271000.00
ICCM cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 125000.00
ICCM cash_flow (quarterly, 2026-03-31) — Change In Inventory: -21000.00
ICCM cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 87000.00
ICCM cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -389000.00
ICCM cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 236000.00
ICCM cash_flow (quarterly, 2026-03-31) — Change In Payable: 125000.00
ICCM cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 125000.00
ICCM cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -337000.00
ICCM cash_flow (quarterly, 2026-03-31) — Change In Receivables: 57000.00
ICCM cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -242000.00
ICCM cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 57000.00
ICCM cash_flow (quarterly, 2026-03-31) — Changes In Cash: -785000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Common Stock: 0.00
ICCM balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 8494000.00
ICCM cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 3537000.00
ICCM income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 616000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Current Assets: 12124000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 134000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 134000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 4804000.00
ICCM cash_flow (quarterly, 2026-03-31) — Depreciation: 69000.00
ICCM cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 69000.00
ICCM cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 69000.00
ICCM income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 2452442.00
ICCM income_statement (quarterly, 2026-03-31) — Diluted EPS: -1.80
ICCM income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -4274000.00
ICCM income_statement (quarterly, 2026-03-31) — EBIT: -4247000.00
ICCM income_statement (quarterly, 2026-03-31) — EBITDA: -4178000.00
ICCM cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 3000.00
ICCM cash_flow (quarterly, 2026-03-31) — End Cash Position: 8115000.00
ICCM cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 3537000.00
ICCM cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -4322000.00
ICCM income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1263000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1127000.00
ICCM income_statement (quarterly, 2026-03-31) — Gross Profit: 295000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Inventory: 2646000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Invested Capital: 8494000.00
ICCM cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -51000.00
ICCM cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 3537000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 5000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 5000.00
ICCM cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 3537000.00
ICCM cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -4000.00
ICCM income_statement (quarterly, 2026-03-31) — Net Income: -4274000.00
ICCM income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -4274000.00
ICCM income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -4274000.00
ICCM income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -4274000.00
ICCM income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -4274000.00
ICCM cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -4274000.00
ICCM income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -4274000.00
ICCM income_statement (quarterly, 2026-03-31) — Net Interest Income: -27000.00
ICCM income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -27000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Net PPE: 1127000.00
ICCM cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -51000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 8494000.00
ICCM income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -4178000.00
ICCM income_statement (quarterly, 2026-03-31) — Normalized Income: -4274000.00
ICCM cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -4271000.00
ICCM cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -4000.00
ICCM income_statement (quarterly, 2026-03-31) — Operating Income: -4247000.00
ICCM income_statement (quarterly, 2026-03-31) — Operating Revenue: 911000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 2706001.00
ICCM balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 787000.00
ICCM income_statement (quarterly, 2026-03-31) — Other Gand A: 1263000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 52000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Other Properties: 1127000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Other Receivables: 1089000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Payables: 988000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 988000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2895000.00
ICCM income_statement (quarterly, 2026-03-31) — Pretax Income: -4274000.00
ICCM cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -51000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Receivables: 1363000.00
ICCM income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 616000.00
ICCM income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 69000.00
ICCM income_statement (quarterly, 2026-03-31) — Research And Development: 2211000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -124710000.00
ICCM income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 1068000.00
ICCM income_statement (quarterly, 2026-03-31) — Selling General And Administration: 2331000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Share Issued: 2706001.00
ICCM cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 180000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 8494000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 8494000.00
ICCM income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ICCM income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
ICCM balance_sheet (quarterly, 2026-03-31) — Total Assets: 13303000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 8494000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Total Debt: 139000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 8494000.00
ICCM income_statement (quarterly, 2026-03-31) — Total Expenses: 5158000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4809000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1179000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 5000.00
ICCM income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -4247000.00
ICCM income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: 27000.00
ICCM balance_sheet (quarterly, 2026-03-31) — Working Capital: 7320000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — +Operating Expense: -35461000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — +Total Revenue: 12747000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 1224000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 716000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -5936000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 33334000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 21536000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 13026700.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Basic EPS: 4.48
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 724000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 41680000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -2956000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 4468000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 130267000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 784000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 52293000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 784000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Change In Payable: -326000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Change In Receivables: -65108000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: -65434000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Changes In Cash: 60000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Common Stock: 130267000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 252138000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 4786000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Current Assets: 121274000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 0.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Current Debt: 4791000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 4791000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 0.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 8332000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Depreciation: 3320000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 3320000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 3320000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 3320000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 13026700.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Diluted EPS: 4.48
ICDSLTD.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 58356000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 1069000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — EBIT: 60068000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — EBITDA: 63388000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — End Cash Position: 784000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 9186000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: 3142000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: -8347000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: 446000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: 0.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 4139000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 42941000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Gross Profit: 7961000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Interest Expense: 702000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 702000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Interest Income: 2137000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 2137000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -252000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 1361000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 256929000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: 2309000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Investment Properties: 70369000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 9186000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 4468000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 4468000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 1146000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Minority Interests: 0.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Net Debt: 4007000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Net Income: 58356000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 58356000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 58356000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 58356000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 58356000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 59366000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 58356000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Net Interest Income: 1406000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 2398000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 3394000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 3394000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: 1406000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: 437000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Net PPE: 37005000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -2956000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 3394000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 252138000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 5621000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 0.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 8277000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: 48851000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Normalized Income: 44079212.30
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: -5391000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Operating Income: 43422000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Operating Revenue: 12747000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 13026700.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 406000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 450000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 121871000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: -1779000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 211000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 1153000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 1000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: -44454000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Other Payable: 589000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Other Properties: 115000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 66195000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 51509000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Other Special Charges: -65218000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Payables: 1813000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 444000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 662000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Pretax Income: 59366000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: 0.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -2956000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 4786000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 3320000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 402000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 402000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 1002000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 54549000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 2398000.00
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 0.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 204000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 4343000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Share Issued: 13026700.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Special Income Charges: 14537000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 252138000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 252138000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 260212.30
ICDSLTD.NS income_statement (annual, 2022-03-31) — Tax Provision: 1010000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.02
ICDSLTD.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -1310000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Total Assets: 266091000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 252138000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Total Debt: 4791000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 252138000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Total Expenses: -30675000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 13953000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 144817000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 5621000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 29000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 0.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Total Unusual Items: 14537000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 14537000.00
ICDSLTD.NS balance_sheet (annual, 2022-03-31) — Working Capital: 112942000.00
ICDSLTD.NS income_statement (annual, 2022-03-31) — Write Off: 50681000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — +Operating Expense: 15548000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — +Total Revenue: 22593000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 1161000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 797000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -7871000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 33334000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 40000000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 13026700.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Basic EPS: 0.29
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 784000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 41680000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -64000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 0.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 130267000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 729000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 80079000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 729000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Change In Payable: 56000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 66037000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 66093000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -55000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Common Stock: 130267000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 255132000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 6036000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Current Assets: 90586000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 0.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Current Debt: 2955000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 2955000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 0.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 5762000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Depreciation: 3637000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 3637000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 3637000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 3637000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 13026700.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Diluted EPS: 0.29
ICDSLTD.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 3805000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 1454000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — EBIT: 5965000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — EBITDA: 9602000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — End Cash Position: 729000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 9231000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -1965000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 63559000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -4382000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -16000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 3922000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 797000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 43005000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Gross Profit: 16557000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Interest Expense: 626000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 626000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Interest Income: 4925000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 4925000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -129000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 1911000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 258087000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -61713000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 68667000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 49231000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 1146000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Net Debt: 2226000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Net Income: 3805000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 3805000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 3805000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 3805000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 3805000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 5339000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 3805000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Net Interest Income: 4287000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 1016000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -1836000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 4287000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -66046000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Net PPE: 35134000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -48000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -1836000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 255132000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 7431000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 0.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 9039000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 9586000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Normalized Income: 3793597.12
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 63623000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Operating Income: 1009000.00
ICDSLTD.NS income_statement (annual, 2023-03-31) — Operating Revenue: 22593000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 13026700.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 94000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 536000.00
ICDSLTD.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 124865000.00
ICDSLTD.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -4789000.00